Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

BCLIBCLI
4 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in BrainStorm Cell Therapeutics In

BANK OF AMERICA CORP /DE/ previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$241

Total Shares Change

-106

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Increased
136
+22.5%
$1520.0%$1.06
9
2025-Q1
Increased
111
+4.7%
$1400.0%$1.19
8
2024-Q4
New
106
-
$2410.0%$2.37
17

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used